Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
34.04
-0.31 (-0.90%)
At close: May 22, 2026, 4:00 PM EDT
34.71
+0.67 (1.97%)
After-hours: May 22, 2026, 5:44 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.44 billion as of May 22, 2026. Its market cap has increased by 69.38% in one year.
Market Cap
2.44B
Enterprise Value
1.92B
1-Year Change
69.38%
Ranking
Category
Stock Price
$34.04
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.44B, an increase of 984.68%. That is a compound annual growth rate of 60.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 2.47B | -31.41% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 2.63B |
| Relay Therapeutics | 2.62B |
| Immunome | 2.60B |
| IDEAYA Biosciences | 2.60B |
| Enliven Therapeutics | 2.57B |
| Disc Medicine | 2.56B |
| Mineralys Therapeutics | 2.49B |
| Definium Therapeutics | 2.47B |